Compound Detail
CHEMBL271141
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Cc1ccc(NC(=O)c2ccc3c(c2)OC(F)(F)O3)cc1C(=O)Nc1cnc(Nc2ccc(N3CCN(C)CC3)cc2)nc1
Basic Information
| ChEMBL ID | CHEMBL271141 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | FWYVIDHPTFCOBL-UHFFFAOYSA-N |
5
Targets
5
Activities
1
Assay Types
6
PK Parameters
10
Publications
0
Known Names
Molecular Properties
601.6
MW (Da)
5.11
ALogP
9
HBA
3
HBD
121.0
PSA (Ų)
0.27
QED
2
Ro5 Violations
7
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 5 meas. best 8.89
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Tyrosine-protein kinase Lck CHEMBL258 | IC50 | 8.89 | 8.89 | 1.3 | 1 |
| Mitogen-activated protein kinase 14 CHEMBL260 | IC50 | 8.0 | 8.0 | 10.0 | 1 |
| Blood CHEMBL613416 | IC50 | 7.89 | 7.89 | 13.0 | 1 |
| Lymphocyte CHEMBL612599 | IC50 | 7.24 | 7.24 | 58.0 | 1 |
| Vascular endothelial growth factor receptor 2 CHEMBL279 | IC50 | 6.57 | 6.57 | 272.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| AUC | 58.0 | ng.hr.mL-1 | Rattus norvegicus |
| CL | 22.83 | mL.min-1.kg-1 | Rattus norvegicus |
| Cmax | 26.6 | nM | Rattus norvegicus |
| F | 4.0 | % | Rattus norvegicus |
| T1/2 | 2.5 | hr | Rattus norvegicus |
| Tmax | 0.42 | hr | Rattus norvegicus |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Tyrosine-protein kinase Lck | IC50 | = | 1.3 | nM | 8.89 | Inhibition of Lck by HTRF assay | 18321037 |
| Mitogen-activated protein kinase 14 | IC50 | = | 10.0 | nM | 8.0 | Inhibition of p38alpha by HTRF assay | 18321037 |
| Blood | IC50 | = | 13.0 | nM | 7.89 | Inhibition of anti-CD3-induced IL2 production in human whole blood by ELISA | 18321037 |
| Lymphocyte | IC50 | = | 58.0 | nM | 7.24 | Inhibition of T cell activation in human peripheral blood lymphocytes by mixed l... | 18321037 |
| Vascular endothelial growth factor receptor 2 | IC50 | = | 272.0 | nM | 6.57 | Inhibition of KDR by HTRF assay | 18321037 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 18321037 | 10.1021/jm7010996 | Rattus norvegicus | 7 |
| 18321037 | 10.1021/jm7010996 | Plasma | 3 |
| 18321037 | 10.1021/jm7010996 | Tyrosine-protein kinase Lck | 1 |
| 18321037 | 10.1021/jm7010996 | Angiopoietin-1 receptor | 1 |
| 18321037 | 10.1021/jm7010996 | Mitogen-activated protein kinase 14 | 1 |
| 18321037 | 10.1021/jm7010996 | Tyrosine-protein kinase JAK3 | 1 |
| 18321037 | 10.1021/jm7010996 | Lymphocyte | 1 |
| 18321037 | 10.1021/jm7010996 | Vascular endothelial growth factor receptor 2 | 1 |
| 18321037 | 10.1021/jm7010996 | Unchecked | 1 |
| 18321037 | 10.1021/jm7010996 | Blood | 1 |
Data from ChEMBL 36 via Core Engine